BioNSW and AusBiotech sign MoU to Deepen Collaboration BioNSW, a rapidly growing not-for-profit organisation, dedicated to harnessing the full potential of the New South Wales Life Sciences sector, has formalised a new partnership with AusBiotech, Australia’s national industry body representing more than 3,000 life sciences members. The signing of this Memorandum of Understanding (MOU) represents a significant step forward in promoting a connected and thriving biotechnology ecosystem across NSW and beyond. The partnership underscores a shared commitment to catalysing innovation, investment, and skills development across the sector. Together, BioNSW and AusBiotech will work to amplify the strengths of NSW’s biotechnology industry, accelerating cross-sector collaboration and promoting growth. Brad Walsh, Acting Chair and Co-Founder of BioNSW, said: “As Acting Chair and Co-Founder of BioNSW, I’m delighted to see the formalisation of this partnership with AusBiotech, a key step forward in strengthening the biotechnology ecosystem across New South Wales and beyond. "The NSW LifeSciences Sector is significant in size and importance with the largest number of Biotech companies amongst the Australian states and territories – with the sector having doubled in size over the last 7 years. "BioNSW is committed to amplifying the voice of our local Life Sciences organisations across all regions of NSW, ensuring that the unique needs and opportunities of the State’s Life Sciences community are well-represented at every level. This partnership with the national peak body AusBiotech underscores our role as a vital advocate, connecting businesses, fostering innovation, and promoting growth. “By working together with AusBiotech, BioNSW is excited to help drive the development of a thriving, connected biotechnology sector in NSW, positioning the state as a leader in the global bio-economy.” Established in 2023 as a Not-for-Profit Organisation, BioNSW is led by an experienced Cross-Sector Board and supported by a group of Expert Committees covering areas ranging from Biotech, MedTech, Digital Health through to Manufacturing, Commercialisation and Investment. #bionsw #ausbiotech #lifesciences #innovation #partnerships #NSW #collaboration #growth
BioNSW
Industry Associations
Sydney, New South Wales 1,538 followers
The peak body for Life Sciences companies and professionals in New South Wales
About us
BioNSW is the non-for-profit, industry association for Life Sciences in New South Wales, Australia. We hope to represent and connect innovators, investors, manufacturers and legislators across the state.
- Website
-
http://www.bionsw.org/
External link for BioNSW
- Industry
- Industry Associations
- Company size
- 2-10 employees
- Headquarters
- Sydney, New South Wales
- Type
- Nonprofit
- Founded
- 2023
Locations
-
Primary
Sydney, New South Wales 2000, AU
Employees at BioNSW
-
Mark Flynn
Chief Medical Officer - Hearing Solutions, Medtech, Clinical Strategy, Patient Experience & Strategy, Executive Leadership & Innovation, Global…
-
Julie Ince-Demetriou, PhD
Executive Director, Research NBCF• Founder and Director, BioCollab Pty Ltd• Clinical Development • Strategic Advisor • Stakeholder Engagement •…
-
Michael Christie
-
Duncan Macinnis
Director of Stakeholder Engagement (NSW/ACT) at MTPConnect
Updates
-
BioNSW are thrilled to announce the signing of a new Memorandum of Understanding (MoU) with AusBiotech! This collaboration marks a significant milestone as we continue to expand our reach and strengthen partnerships within the Life Sciences sector. BioNSW has been growing rapidly, and this MoU is an important step in building on our existing agreements with key industry players, including BioMelbourne, Life Sciences Queensland, ARCS and Pathology Technology Australia. This partnership with AusBiotech will help us accelerate our plans for the NSW Life Sciences ecosystem, supporting growth and innovation well into 2025 and beyond. We look forward to what the future holds as we continue to drive progress in the life sciences sector! #BioNSW #LifeSciences #Innovation #Partnerships #AusBiotech #NSW #Collaboration #Healthcare #Biotech #Growth
#AusBiotech and BioNSW have signed a Memorandum of Understanding (MOU), marking a key milestone in building a connected and thriving biotechnology ecosystem across NSW and beyond. The MOU underscores a shared commitment to catalysing innovation, investment, and skills development across the industry. Rebekah Cassidy, CEO of AusBiotech, stated: “I couldn’t be more pleased to sign this MOU with BioNSW. It reflects our shared commitment to growing Australia’s life sciences capabilities and reinforces AusBiotech’s commitment to fostering a connected biotechnology sector. I look forward to working with the BioNSW team to showcase the state’s strengths and offerings.” “My consistent message has been that, as the leading national advocate, we have a responsibility to collaborate and deepen our relationships with our partners in each of the states, including New South Wales. Through our own thriving membership, we know that NSW's biotech and medtech community is exciting and strong. Coordinating locally and nationally to foster joint advocacy is a critical enabler for the future of our sector. Unifying the sector's voice must be one of our most critical, shared priorities.” Robyn Lindner, Brad Walsh #LifeSciences #Collaboration #Biotech #Medtech
-
Leadership Update from BioNSW It is with mixed emotions that the Board of BioNSW announces that Anthony Murray, our inaugural Chairman, has returned to the United Kingdom for personal reasons. Anthony, along with his co-founder Brad Walsh, played a pivotal role in the establishment of BioNSW and was a driving force behind our successful first year. His leadership, vision, and passion for the life sciences sector have made a lasting impact on BioNSW’s growth and direction. As Anthony transitions, Brad Walsh will step into the role of Acting Chairman. Brad shared, "On behalf of the BioNSW Board of Directors, I want to express our sincere thanks to Anthony for his dedication and leadership. We wish him all the best in the UK and look forward to welcoming him back to NSW in the future." BioNSW is a membership organisation dedicated to catalysing life sciences innovation by connecting, promoting, and representing the companies and professionals of NSW. We look forward to continuing to build on the strong foundation that Anthony helped lay and working together with our members to drive progress in the sector. #LeadershipTransition #LifeSciences #Innovation #BioNSW #BoardAnnouncement
-
BioNSW welcomes yesterday's announcement by the Minister for Industry and Science, the Hon. Ed Husic MP, and the Minister for Education, the Hon. Jason Clare MP of the Terms of Reference for the Strategic Examination of Australia's R&D Performance (which had been foreshadowed in the May 2024 Federal Budget). BioNSW also congratulates the R&D Review Chair (Robyn Denholm) and the Review Panelists (Dr Kate Cornick, Emeritus Professor Ian Chubb AC and Professor Fiona Wood AO) on their appointments to this important Review. This Strategic Examination will assess the economic growth and productivity benefits from Australia's R&D Performance - with its findings due to be reported by the end of 2025. With Medical Science being an important national priority, BioNSW is supportive of recognising, strengthening and maximising opportunities for keeping R&D value on shore for longer – for the benefit of Australia and Australians. BioNSW are a Not-for-Profit Organisation dedicated to harnessing the full potential of the NSW Life Sciences sector and catalysing innovation, investment, skills and jobs for economic growth, prosperity and a healthier community. More information on the Strategic Examination of R&D Review and Panelists can be found here: https://lnkd.in/ggdhqREW
-
Join us at the Joint BioNSW BioMelbourne Network event in Sydney on Friday December 6. An insightful free event exploring the latest innovations in targeted drug delivery systems. Discover advances in nasal, pulmonary, ophthalmic, and dermal drug delivery for more effective and patient-centered treatment solutions. Speakers from Aptara, AbInitio and Encap Solutions #drugdelivery #biotechnology #BioNSW
Targeted Drug Delivery Innovations
bionsw.org
-
BioNSW was recently invited by Foley to provide a briefing to the visiting Wisconsin Economic Development Corporation trade mission on opportunities for collaboration with NSW Life Sciences organisations. This productive briefing with WEDC provided another chance for BioNSW to promote the strength and diversity of the NSW Life Science ecosystem - and to learn more about potential partners in the Wisconsin BioHealth sector. BioNSW helps catalyse Life Sciences innovation by Connecting, Promoting and Representing the companies and professionals of NSW.
Wisconsin Trade Mission arrives in Australia! Foley would like to extend a very warm welcome to the Wisconsin Economic Development Corporation who are in Australia this week for a multi-sector Trade Mission led by WEDC's CEO & Secretary Missy Hughes. A diverse range of companies from Wisconsin have joined the mission for a week of meetings and engagement to expand relations between Wisconsin and Australia. We welcome: Vx Group Optimum Crush, Inc. Weinbrenner Shoe Co Inc Dairy Farmers of Wisconsin CareFree Enzymes, Inc. DynaVap Baso Gas Products LLC Hydro-Thermal Corporation Vector Technologies Ltd. Missy Hughes Chad Hoffman, CGBP Megan Otto Jennifer Lu Giovanni Munoz Angela Foley Laurie Price Rae Davis Mirna Sarihodzic Steve Berg Nathan Ho Juliet Gollan Lee Lon Wong Chris Evans Wisconsin Economic Development Corporation Foley Wisconsin Department of Agriculture, Trade and Consumer Protection #US #Australia #trade #partnership #international
-
BioNSW is proud to see today's announcement of the appointment of one of our Non-Executive Directors, Kathy Connell, GAICD to the Board of Directors of Opthea
Kathy Connell, GAICD is a commercial executive with deep business development expertise. Her track record of translating global commercial strategies into impactful business results and shareholder value will be instrumental as Opthea prepares for the topline data readout of its pivotal program of sozinibercept in wet AMD. For more details, please read the press release: https://lnkd.in/eJMN6rz6 #Opthea #maculardegeneration #AMDResearch #wetAMD #ophthalmology #medicaleducation #biopharma #eyehealth #retinaspecialists #sozinibercept
-
Last night BioNSW had the pleasure of joining with ARCS Australia and AusBiotech to host a memorable End of Year get together in North Sydney for the NSW Life Sciences Sector. With almost 300 people registering to attend it was an important indication of the strength and connectivity of the NSW Life Sciences Sector - as well as the value of ongoing collaboration with our other key partners. BioNSW is an ambitious Not-For-Profit Organisation dedicated to supporting the growth of the NSW Life Sciences Sector.
-
+1
-
The recent visit of the Duchess of York, Sarah Ferguson, was a special opportunity for the Children's Medical Research Institute (one of BioNSW Corporate Members) to showcase the research contributions of the NSW Life Sciences Sector.
It was our great honour to welcome Duchess of York, Sarah Ferguson, into our labs today to meet our scientists and ambassador families. As a cancer survivor she was greatly interested in our work and took the time to sign copies of her new book for the children. We deeply appreciate the light she has shone on the importance of our research. #DuchessofYork #SarahFerguson #CancerResearch #Childrenshealth #ProCan